Diuron is a white crystalline solid. It is a wettable powder. The primary hazard is the threat to the environment. Immediate steps should be taken to limit its spread to the environment. It can cause illness by inhalation, skin absorption and/or ingestion. It is used as a herbicide.
颜色/状态：
White, crystalline solid
气味：
Odorless
蒸汽压力：
8.25X10-9 mm Hg (1.1X10-3 mPa) at 25 °C
稳定性/保质期：
高浓度时，该物质会对眼睛和黏膜产生刺激作用。
分解：
Diuron, stable under normal conditions, decomposed on heating to 180 to 190 °C giving dimethylamine and 3,4-dichlorophenyl isocyanate.
Diuron is carcinogenic to the rat urinary bladder at high dietary levels. The proposed mode of action (MOA) for diuron is urothelial cytotoxicity and necrosis followed by regenerative urothelial hyperplasia. Diuron-induced urothelial cytotoxicity is not due to urinary solids. Diuron is extensively metabolized, and in rats, N-(3,4-dichlorophenyl)urea (DCPU) and 4,5-dichloro-2-hydroxyphenyl urea (2-OH-DCPU) were the predominant urinary metabolites; lesser metabolites included N-(3,4-dichlorophenyl)-3-methylurea (DCPMU) and trace levels of 3,4-dichloroaniline (DCA). In humans, DCPMU and DCPU have been found in the urine after a case of product abuse. To aid in elucidating the MOA of diuronand to evaluate the metabolites that are responsible for the diuron toxicity in the bladder epithelium, we investigated the urinary concentrations of metabolites in male Wistar rats treated with 2500 ppm of diuron, the urothelial cytotoxicity in vitro of the metabolites and their gene expression profiles. DCPU was found in rat urine at concentrations substantially greater than the in vitro IC50 and induced more gene expression alterations than the other metabolites tested. 2-OH-DCPU was present in urine at a concentration approximately half of the in vitro IC50, whereas DCPMU and DCA were present in urine at concentrations well below the IC50. For the diuron-induced MOA for the rat bladder, we suggest that DCPU is the primary metabolite responsible for the urothelial cytotoxicity with some contribution also by 2-OH-DCPU. This study supports a MOA for diuron-induced bladder effects in rats consisting of metabolism to DCPU (and 2-OH-DCPU to a lesser extent), concentration and excretion in urine, urothelial cytotoxicity, and regenerative proliferation.
This study was designed to investigate diuron biotransformation and disposition ... . The only metabolic pathway detected by liquid chromatography/mass spectometry in human liver homogenates and seven types of mammalian liver microsomes including human was demethylation at the terminal nitrogen atom. No other phase I or phase II metabolites were observed. The rank order of N-demethyldiuron formation in liver microsomes based on intrinsic clearance (V(max)/K(m)) was dog > monkey > rabbit > mouse > human > minipig > rat. All tested recombinant human cytochrome P450s (P450s) catalyzed diuron N-demethylation and the highest activities were possessed by CYP1A1, CYP1A2, CYP2C19, and CYP2D6. Relative contributions of human CYP1A2, CYP2C19, and CYP3A4 to hepatic diuron N-demethylation, based on average abundances of P450 enzymes in human liver microsomes, were approximately 60, 14, and 13%, respectively. Diuron inhibited relatively potently only CYP1A1/2 (IC(50) 4 uM)...
3,4-dichloroaniline (3,4-DCA) is a metabolite of diuron as well as two other pesticides, linuron and propanil. However, EPA's Metabolism Assessment Review Committee (MARC) concluded that residues of 3,4-DCA should not be aggregated for the diuron, linuron, and propanil risk assessments because 3,4-DCA is significant residue of concern for propanil, but is not a residue of concern per se for diuron or linuron. Although the analytical method for quantifying residues of concern from diuron converts all residues to 3,4-DCA as a convenience, 3,4-DCA was not a significant residue in any metabolism or hydrolysis study.
... In ... a woman poisoned with Diuron, 1-(3,4-dichlorophenyl)-3,3-dimethylurea, plus 3-amino-1,2,4-triazole, 1-(3,4-dichlorophenyl)-3-methylurea, and 1-(3,4-dichlorophenyl)urea were isolated from urine. The urine probably contained small amt of 3,4-dichloroaniline, but no unchanged herbicide.
来源:Hazardous Substances Data Bank (HSDB)
代谢
Diuron has known human metabolites that include N-demethyldiuron.
迪uron已知的人类代谢物包括N-去甲基迪uron。
Diuron has known human metabolites that include N-demethyldiuron.
IDENTIFICATION AND USE: Diuron is a solid. Diuron is a photosynthesis inhibitor that is used mainly for general weed control on noncrop areas. It has also been used in the selective control of germinating broadleaf and grass weeds in sugarcane, citrus, pineapples, cotton, asparagus, and temperate climate tree and bush fruits. It is also used as a soil sterilant. HUMAN STUDIES: It may irritate the skin, eyes, or nose. Diuron is cytotoxic in vitro in human cells and oxidative stress contributes to its toxicity. The victim of a suicide attempt did not show signs of intoxication after ingesting diuron and amitrole preparation. ANIMAL STUDIES: It caused irritation to eyes and mucous membranes of rabbits but a 50% water paste was not irritating to intact skin of guinea pigs. Diuron at high dietary levels (2500 ppm) induces rat urinary bladder hyperplasia after 20 weeks of exposure. It was also noted that genes related to the aryl hydrocarbon receptor signaling were upregulated in rats exposed to the diuron high dose (1250 and 2500 ppm). Diuron induced high incidences of urinary bladder carcinomas and low incidences of kidney pelvis papillomas and carcinomas in rats exposed to high doses (2500 ppm) in a 2-year bioassay. The proposed rat urothelial mode of action for this herbicide consists of metabolic activation to metabolites that are excreted and concentrated in the urine, leading to cytotoxicity, urothelial cell necrosis and exfoliation, regenerative hyperplasia, and eventually tumors. At 2500 ppm for 2 years, both rats and dogs showed growth retardation, slight anemia, presence of abnormal pigment, increased erythropoiesis, and splenic hemosiderosis. Some rats showed splenic enlargement, and dogs showed liver enlargement. Diuron at 750 ppm induced male offspring toxicity but these alterations were not permanent, as evidenced by absence of reproductive-system alterations in adult rats. A dietary concentration of 125 ppm did not adversely affect reproduction in a three-generation rat study. In rat developmental studies, reduction in mean fetal weight at 500 mg/kg was noted, and 250 mg/kg increased the number of anomalous fetuses. In zebrafish studies, changes in behavior, such as decrease in spontaneous coiling movements of embryos and reduction of thigmotaxis in larvae, were pronounced for diuron. Diuron was active in vitro when tested for endocrine disrupting potential. Diuron was tested in Salmonella strains TA1535, TA97, TA98, and TA100 with metabolic activation at 0, 10, 25, 50, 100, or 250 ug/plate and without activation at 0, 0.5, 1, 2.5, 5, or 10 ug/plate. No increase in reversion rate reported. Cytotoxicity with TA1535. ECOTOXICITY STUDIES: Diuron metabolites had estrogenic effects potentially mediated through enhanced estradiol biosynthesis and accelerated the ovarian development of Nile tilapia females. Further studies indicated that biotransformation of diuron to active metabolites alter signaling pathways of the CNS which may impact androgen and the stress response as well as behavior necessary for social dominance, growth, and reproduction in fish. Exposure to a concentration of diuron that is frequently encountered in the field during the oyster's gametogenesis stage can impact the next generation and may result in fitness disturbance. Negative effect of diuron on oyster reproduction potentiated by inducing both structural and functional modifications of the DNA. Further in oysters, parental diuron exposure has an impact on the DNA methylation pattern of its progeny. The effect of the herbicide diuron was evaluated using a recycling multi compartment algae, Daphnia magna, bacteria microecosystem. A concentration of 0.2 ppm diuron was lethal to the Daphnia magna population. Diuron had an effect on newly born animals, and therefore these did not mature. Diuron was correlated with severe and widespread dieback of the dominant mangrove, Avicennia marina (Forsk.) Vierh. var. eucalyptifolia (Val.) N.C. Duke (Avicenniaceae), its reduced canopy condition, and declines in seedling health within three neighbouring estuaries in the Mackay region of NE Australia. The likely consequences of such dieback included declines in coastal water quality with increased turbidity, nutrients and sediment deposition, as well as further dispersal of the toxic chemicals.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
毒性总结
敌草隆据报道能够与雄激素受体结合。这表明敌草隆可能会阻断这些受体，导致对生殖系统的毒性。
Diuron has been reported to bind to androgen receptors. This suggests that diuron may block the receptors and result in the toxicity on the reproductive system.
来源:Toxin and Toxin Target Database (T3DB)
毒理性
致癌性证据
癌症分类：已知/很可能/对人类致癌/
Cancer Classification: Known/ Likely /to be Carcinogenic to Humans/
Diuron is readily absorbed through the gastrointestinal tract in rats and dogs. Tissue level of diuron were positively correlated with dosage. No apparent storage of diuron in tissues was noted ... Diuron is also partially excreted unchanged in feces and urine.
Root uptake of (14)C-Diuron from solution was studied. ... small amount of the monomethyl and demethylated derivatives were found in nutrient solution from ... soybeans, ... oat, and corn tops.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
敌草隆主要通过根系吸收；通过叶片和茎部吸收较少。在木质部中，其主要向上转移。
Diuron is most readily absorbed through the root system; less so through foliage & stems. Translocation is primarily upward in xylem.
Diuron was fed to five dairy cows at 0-550 ppm concentration levels. About 50% of the diuron was detected in the urine, 10% in the feces and 5% in the blood. Milk samples did not contain diuron. A positive correlation was noted between the concn of diuron products in urine and blood and a negative correlation between urine and feces. It is suggested that the remaining diuron is absorbed in the body or degraded into undetectable metabolites.
Estimation of dioxin emission from fires in chemicals
摘要：
The formation of the 17 toxic 2,3,7,8-substituted PCDDs and PCDFs during combustion of selected chemicals were measured by high-resolution GC/MS. The 16 chemicals studied were commonly used chlorinated pesticides, industrial chemicals, and PVC. In a series of experiments carried out in a DIN 53,436 furnace, 2.5 g of these compounds were burned at 500 degrees C and 900 degrees C, respectively. The resultant yields ranged from 740 ng ITEQ/g for pentachlorophenol, to below 0.01 ng ITEQ/g for PVC and dichlobenil. The results show that some chemicals generate PCDD/F in very high possibly dangerous - amounts during burning, whereas others generate insignificant amounts. The influence of scale were studied for chlorobenzene and 4-chloro-3-nitro-benzoic acid in additional experiments, carried out in a cone calorimeter burning 20 g substance, and in ISO 9705 room test burning about 50 kg. A good agreement between the results for large and small scale indicated that formation of PCCD/F during a fire may be estimated from laboratory experiments. This suggest laboratory test may be used to screen for chemicals posing a hazard for release of PCDD/F during fires. (C) 1999 Elsevier Science Ltd. All rights reserved.
This work describes an effective and a safe procedure for the preparation of commercially applicable trisubstituted ureas derived from their thio analogues which result from the thiuram disulfides in quantitative yields.
Synthesis of Double-Chain Bis-Sulfone Neoglycolipids of the 2-, 3-, and 6-Deoxyglobotrioses
摘要：
Partially protected 2-(trimethylsilyl)ethyl 2- and 3-deoxyglucosides and 6-deoxylactoside were synthesised via various routes and glycosylated with galabiosyl and galactosyl donors to give the corresponding deoxytrisaccharides. Removal of the protecting groups gave the 2-(trimethylsilyl)ethyl 2-, 3-, and 6-deoxyglobotriosides. Transformation of the protected trisaccharides into trichloroacetimidates, via the corresponding hemiacetals, proceeded in similar to 80% overall yield. Glycosylation of 3-(hexadecylsulfonyl)-2-[(hexadecylsulfonyl)methyl]propanol with the trisaccharidic trichloroacetimidates, in 72-79% yield, followed by removal of protecting groups, gave the title neoglycolipids.
[EN] ACC INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE L'ACC ET UTILISATIONS ASSOCIÉES
申请人：GILEAD APOLLO LLC
公开号：WO2017075056A1
公开（公告）日：2017-05-04
The present invention provides compounds I and II useful as inhibitors of Acetyl CoA Carboxylase (ACC), compositions thereof, and methods of using the same.
[EN] 3-[(HYDRAZONO)METHYL]-N-(TETRAZOL-5-YL)-BENZAMIDE AND 3-[(HYDRAZONO)METHYL]-N-(1,3,4-OXADIAZOL-2-YL)-BENZAMIDE DERIVATIVES AS HERBICIDES<br/>[FR] DÉRIVÉS DE 3-[(HYDRAZONO))MÉTHYL]-N-(TÉTRAZOL-5-YL)-BENZAMIDE ET DE 3-[(HYDRAZONO)MÉTHYL]-N-(1,3,4-OXADIAZOL-2-YL)-BENZAMIDE UTILISÉS EN TANT QU'HERBICIDES
申请人：SYNGENTA CROP PROTECTION AG
公开号：WO2021013969A1
公开（公告）日：2021-01-28
The present invention related to compounds of Formula (I): or an agronomically acceptable salt thereof, wherein Q, R2, R3, R4, R5 and R6 are as described herein. The invention further relates to compositions comprising said compounds, to methods of controlling weeds using said compositions, and to the use of compounds of Formula (I) as a herbicide.
[EN] INSECTICIDAL TRIAZINONE DERIVATIVES<br/>[FR] DÉRIVÉS DE TRIAZINONE INSECTICIDES
申请人：SYNGENTA PARTICIPATIONS AG
公开号：WO2013079350A1
公开（公告）日：2013-06-06
Compounds of the formula (I) or (I'), wherein the substituents are as defined in claim 1, are useful as pesticides.
式(I)或(I')的化合物，其中取代基如权利要求1所定义的那样，可用作杀虫剂。
Inhibitors of histone deacetylase
申请人：——
公开号：US20020177594A1
公开（公告）日：2002-11-28
Compounds having the formula
1
or therapeutically acceptable salts thereof, are histone deacetylase (HDAC) inhibitors. Preparation of the compounds, compositions containing the compounds, and treatment of diseases using the compounds are disclosed.
[EN] SQUALENE COMPOUNDS AS MODULATORS OF LDL-RECEPTOR EXPRESSION<br/>[FR] COMPOSÉS DE SQUALÈNE EN TANT QUE MODULATEURS DE L'EXPRESSION DU RÉCEPTEUR LDL
申请人：ISIS INNOVATION
公开号：WO2016042318A1
公开（公告）日：2016-03-24
The present invention relates to compounds that modify low density lipoprotein receptor (LDLR) expression. The compounds have the structural formula I shown below: wherein m, R1, n, R2 and R3 are each as defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of diseases or disorders associated with elevated levels of low density lipoprotein cholesterol (LDL-C).
